(Q42997948)

12 November 2017

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders (English)

1 reference

12 November 2017

0 references

1 reference

1 reference

1 reference

Nelson DR

1

1 reference

12 November 2017

Lauwers GY

series ordinal

2

1 reference

12 November 2017

Lau JY

series ordinal

3

1 reference

12 November 2017

Davis GL

series ordinal

4

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

12 November 2017

1 reference

12 November 2017

118

1 reference

12 November 2017

655-660

1 reference

12 November 2017

4

1 reference

Clinical outcomes after transfusion-associated hepatitis C.

12 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Pathogenesis of hepatocellular damage in chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Serum levels of cytokines in chronic liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Activation of tumor necrosis factor-alpha system in chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Interleukin-10 inhibits hepatic injury and tumor necrosis factor-alpha and interferon-gamma mRNA expression induced by staphylococcal enterotoxin B or lipopolysaccharide in galactosamine-sensitized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Histological grading and staging of chronic hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Expression of interleukin-10 by in vitro and in vivo activated hepatic stellate cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2800%2970134-X

10.1016/S0016-5085(00)70134-X

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference